Risk-Stratified Evaluation of Amiodarone to Prevent Atrial Fibrillation After Cardiac Surgery

Annals of Thoracic Surgery

Volumn 82, Issue 4, 2006, Pages 1332-1337

  Barnes, Brian J ^a,b   Kirkland, Erin A ^a   Howard, Patricia A ^a   Grauer, Dennis W ^a   Gorton, Michael E ^b   Kramer, Jeffrey B ^b   Muehlebach, Gregory F ^b   Reed, William A ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DATA BASE; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; VALIDATION PROCESS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 33748753261     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.04.081     Document Type: Article

References (31)

1. Mathew J.P., Fontes M.L., Tudor I.C., et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 291 14 (2004) 1720-1729
2. Daoud E.G., Strickberger S.A., Man K.C., et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337 (1997) 1785-1791
3. Redle J.D., Khurana S., Marzan R., et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J 138 (1999) 144-150
4. Katariya K., DeMarchena E., and Bolooki H. Oral amiodarone reduces incidence of postoperative atrial fibrillation. Ann Thorac Surg 68 (1999) 1599-1604
5. Giri S., White C.M., Dunn A.B., et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial. Lancet 357 (2001) 830-836
6. Maras D., Boskovic S.D., Popovic Z., et al. Single-day loading dose of oral amiodarone for the prevention of new-onset atrial fibrillation after coronary artery bypass surgery. Am Heart J 141 (2001) E8
7. White C.M., Giri S., Tsikouris J.P., et al. A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg 74 (2002) 69-74
8. Yazigi A., Rahbani P., Zeid H.A., Madi-Jebara S., Haddad F., and Hayek G. Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. J Cardiothorac Vasc Anesth 16 (2002) 603-606
9. Mitchell L.B., Exner D.V., Wyse D.G., et al. Prophylactic oral amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair (PAPABEAR): a randomized controlled trial. JAMA 294 24 (2005) 3093-3100
10. Butler J., Harriss D.R., Sinclair M., and Westaby S. Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomized, double blind, placebo controlled trial. Br Heart J 70 (1993) 56-60
11. Guarnieri T., Nolan S., Gottlieb S.O., Dudek A., and Lowry D.R. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) Trial. J Am Coll Cardiol 34 (1999) 343-347
12. Lee S.H., Chang C.M., Lu M.J., et al. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 70 (2000) 157-161
13. Dorge H., Schoendube F.A., Schoberer M., Stellbrink C., Voss M., and Messmer B.J. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. Ann Thorac Surg 69 (2000) 1358-1362
14. Tokmakoglu H., Kandemir O., Gunaydin S., Catav Z., Yorgancioglu C., and Zorlutuna Y. Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. Eur J Cardiothorac Surg 21 (2002) 401-405
15. Yagdi T., Nalbantgil S., Ayik F., et al. Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1420-1425
16. White C.M., Caron M.F., Kalus J.S., et al. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation 108 Suppl 2 (2003) II200-II206
17. Auer J., Weber T., Berent R., et al. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot Study of Prevention of Postoperative Atrial Fibrillation (SPPAF), a randomized, placebo-controlled trial. Am Heart J 147 4 (2004) 636-643
18. Solomon A.J., Greenberg M.D., Kilborn M.J., and Katz N.M. Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 142 5 (2001) 811-815
19. Kerstein J., Soodan A., Qamar M., et al. Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. Chest 126 3 (2004) 716-724
20. Mooss A.N., Wurdeman R.L., Sugimoto J.T., et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 148 4 (2004) 641-648
21. DiDomenico R.J., and Massad M.G. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg 79 2 (2005) 728-740
22. Cordarone (amiodarone) package insert. Philadelphia, PA: Wyeth Pharmaceuticals Inc, January 2005.
23. Dusman R.E., Stanton M.S., Miles W.M., et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 82 1 (1990) 51-59
24. Bravo A.E., Drewe J., Schlienger R.G., Krahenbuhl S., Pargger H., and Ummenhofer W. Hepatotoxicity during rapid intravenous loading with amiodarone: description of three cases and review of the literature. Crit Care Med 33 1 (2005) 128-134
25. Cheung A.T., Weiss S.J., Savino J.S., et al. Acute circulatory actions of intravenous amiodarone loading in cardiac surgical patients. Ann Thorac Surg 76 2 (2003) 535-541
26. Mahoney E.M., Thompson T.D., Veledar E., Williams J., and Weintraub W.S. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol 40 4 (2002) 737-745
27. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 44 5 (2004) 1146-1154 e213-310
28. Reddy P., Richerson M., Freeman-Bosco L., Dunn A., White C.M., and Chow M.S. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation in coronary artery bypass surgery. Am J Health Syst Pharm 56 21 (1999) 2211-2217
29. Reddy P., Dunn A.B., White C.M., Tsikouris J.P., Giri S., and Kluger J. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery. Pharmacotherapy 22 1 (2002) 75-80
30. Reddy P., Kalus J.S., Caron M.F., et al. Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. Pharmacotherapy 24 8 (2004) 1013-1019
31. Kim M.H., Rachwal W., McHale C., et al. Effect of amiodarone ± diltiazem ± beta blocker on frequency of atrial fibrillation, length of hospitalization, and hospital costs after coronary artery bypass grafting. Am J Cardiol 89 9 (2002) 1126-1128